Clinical trial NCT04989426: Generalist Cohort of Migrant Patients Consultants in City Medicine
Official title: State of Health and Integration Into the Health Care System of Migrant Patients, New Arrivals, Consultants in Urban Primary Care Structures,in Seine Saint Denis and in the North of Paris.
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Care System for Newly Arrived Migrants
Lead sponsor: Assistance Publique - Hôpitaux de Paris
Sponsor class: OTHER
First posted: 2021-08-04
Enrollment: 197
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: specific population of major newcomer migrants

Brief summary: This innovative cross-sectional study, carried out in the city, will provide valuable prospective data that will make it possible to identify public health avenues for specific and adapted care both in the medical and social field of newcomers to our territory. Our study will characterize the impact of reforms of the conditions of access to State medical aid and universal health protection on access to care and the state of health of this population. . It will make it possible to participate in the advocacy in favor of access to healthcare for all and the city PASS, the only device allowing access to healthcare in the city for all newcomers regardless of their status.

Detailed description: Participants will be informed orally and via an information note written by the doctor during their first medical contact in France or during a follow-up visit within the municipal health center.

The health data comes from the participant's care file and some social data is extracted from the social information system, already existing and used by the reception agents responsible for the consultations. access to rights.

Inclusion visit :

This visit will take place during the first medical visit of eligible patients.

During this visit, the investigative team:

* Checks the inclusion and non-inclusion criteria;
* Gives clear oral and written information;
* Collect the patient's non-opposition;
* Performs the medico-social consultation in accordance with the management recommendations.

Follow-up visits Follow-up will be continued 12 months after the inclusion visit. The rhythm, as well as the nature of the follow-up visits for the patients included, will be defined by the information obtained during the inclusion visit, and will be determined by the doctor in charge of the patient.

For patients included retrospectively The inclusion visit will take place during a follow-up medico-social visit planned as part of the care in one of the participating the municipal health center.

During this visit, the investigative team:

* Checks the inclusion and non-inclusion criteria;
* Gives clear oral and written information;
* Collect the patient's non-opposition;
* Performs the medico-social consultation in accordance with the management recommendations

During the inclusion visit and medical follow-up visits, within the Municipal Health Centers, a consultation on access to rights will also be carried out in order to help patients put together their social file.

Eligibility criteria: Inclusion Criteria:

* Adults (age ≥ 18 years)
* Newly arrived migrants (foreigners born outside France, first arrival in France AND presence in the territory ≤ 1 year)
* 1st medical contact in town medicine in France

Exclusion Criteria:

* Refusal of participation
* Communication impossible due to the language barrier despite translation or interpreting (telephone or face-to-face)

Primary outcomes:
measure: The number of medical and social consultations one year after inclusion.
timeFrame: one year after arrival in France
measure: Number of newcomer biological assessments prescribed by the doctor one year after inclusion
timeFrame: one year after arrival in France
Secondary outcomes:
Other outcomes:
Locations:
city: Aubervilliers
country: France
facility: CMS Aubervilliers
city: Saint-Denis
country: France
facility: CMS Saint-Denis
Study officials:
References: